All 1 tracked stories fall under one category: markets. Of the tracked stories, 1 of 1 also mention Apimeds Pharmaceuticals US, Inc., the most common co-covered peer. Each carries 2 original sources on average. We currently track 1 Finance story that mention Dr. Vin Menon, all published on October 6, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Dr. Vin Menon
All 1 tracked stories fall under one category: markets. Of the tracked stories, 1 of 1 also mention Apimeds Pharmaceuticals US, Inc., the most common co-covered peer. Each carries 2 original sources on average. We currently track 1 Finance story that mention Dr. Vin Menon, all published on October 6, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 3 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Dr. Vin Menon. Shared-story counts are live from our verified record — not editorial picks.
Apimeds Pharmaceuticals unit MindWave announced a two-year build-and-operate agreement with BlockAssure to deploy AssureChain, adding quarterly development fees and a 20% AssureCoin allocation. For APUS investors, the deal is a diversification catalyst into insurance-grade blockchain infrastructure, but the token element remains contingent and unverified.
Dr. Vin Menon is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.